Invesco Biotechnology & Genome ETF
PBE
PBE
73 hedge funds and large institutions have $57.4M invested in Invesco Biotechnology & Genome ETF in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
73
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.38M | |
| 2 | +$1.46M | |
| 3 | +$307K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$205K |
| 5 |
AWM
Avitas Wealth Management
Los Angeles,
California
|
+$116K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$706K | |
| 3 | -$520K | |
| 4 |
Morgan Stanley
New York
|
-$312K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$297K |